Nasdaq
TRVI
Trevi Therapeutics, Inc.
- Health Care
- Listed 2019
- 1 day
- −0.8%
- 1 month
- −5.1%
- 1 year
- +154%
$18.50 · Mkt cap $2.63B
At the 6 Aug 2026 close
Nasdaq
Trevi Therapeutics, Inc.
$18.50 · Mkt cap $2.63B
At the 6 Aug 2026 close
Trevi Therapeutics, Inc. trades under the ticker TRVI on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2019. Its market capitalisation is $2.63B. The last closing price was $18.50, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +154%, and −5.1% over the past month. Returns are price returns and exclude dividends.
This page exists because TRVI is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.